Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heat Biologics Names CFO

This article was originally published in Scrip

Executive Summary

Heat Biologics Inc., an immuno-oncology company, has named Timothy Creech chief financial officer. Most recently, Creech was acting CFO of Salix Pharmaceutical Inc., a publicly-held specialty pharmaceutical company acquired by Valeant for $11bn in April 2015. Prior to his appointment as acting CFO for Salix, Creech held several financial leadership positions at the company over the last seven years including senior vice president of finance and administrative services. Before joining Salix he was vice president of finance and chief accounting officer at Voyager Pharmaceutical Corporation.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC063863

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel